Overlooking the need and avoiding the risks of Covid-19 vaccines

The warp-speed development of an anti-Covid-19 vaccine ignores the non-immune antiviral defense mechanism mediated by the alternative cellular energy (ACE) pathway. This pathway was identified in studies of stealth-adapted viruses. These viruses have deletions or mutations in the genes that encode the relatively few components of the virus that are normally the target of the cellular immune system. Public health authorities have denied the existence of these viruses because some were originally derived from the viruses that infect monkeys used to produce polio vaccines. A novel feature of the stealth adaptation process is that, in addition to losing certain genes, there may be the incorporation of genetic sequences from infected cells. This has allowed the transmission to humans of cellular genes from monkeys.

Although the immune system is restricted in its ability to suppress stealth-adapted viruses, these viruses, and indeed potentially all viruses, can still be suppressed as long as the infected cells have sufficient cellular energy. Symptomatic Covid-19 infection is therefore an indication that the person’s cells have insufficient cellular energy. In contrast, symptomatic infections can be prevented by enhancing the cellular energy of people exposed to the virus. Arguably, this can be achieved by repeatedly inhaling the mist generated by inhaling nebulized water with a high level of a natural energy known as KLELEA, an abbreviation for Kinetic Energy that limits electrostatic attraction. A natural source of water activated by KELEA has been identified in Southern California. It can also be generated using several simple procedures. The current research protocol consists of inhaling the mist of 5 ml of activated water, for a period of 5 minutes, 5 times a day for two days. The main result is the conversion of a positive antigen or PCR test before inhalation for two days to a negative test after the investigation procedure. A secondary outcome is self-reported assessments of changes in symptom severity. This study is registered at ww.clinicaltrials.gov under the identification number NCT04490824.

People infected with stealth-adapted viruses are at special risk from receiving a Covid-19 vaccine. First, the nonspecific immune stimulation of the vaccine may allow immune reactivity against some of the residual components of stealth-adapted viruses. If these viruses reside in the central nervous system, the resulting inflammation can present as multiple sclerosis or transverse myelitis, as has been reported using the AstraZeneca vaccine. Second, stealth-adapted viruses can incorporate themselves and become carriers of foreign genes. If they were pre-existing viruses adapted to stealth to incorporate the DNA or RNA sequence encoding the peak antigen of the Covid-19 vaccine, they could easily disrupt the body’s angiotensin-mediated regulatory system. It is highly unlikely that the Food and Drug Administration (FDA) or vaccine manufacturers will address these considerations. In fact, as noted above, the FDA, and even the National Institutes of Health (NIH), have even refused to acknowledge the existence of stealth-adapted viruses derived from monkeys despite overwhelming DNA sequence data from monkeys. these viruses.

For a disease that causes symptoms in only a small fraction of those infected, it is completely inappropriate to vaccinate everyone. What is more sensitive is having the means to reduce the susceptibility of those who would otherwise develop symptomatic disease. In addition to the direct inhalation of KELEA activated water, benefits appear to occur from the simple use of small bags containing activated water. Activated water can be used in a similar way to humidify closed living spaces. These approaches are facilitated by the location of naturally activated water sources.